You can feel it, can’t you?
Something big just broke...
Not the stock market, not the banks… something deeper.
The numbers say everything’s fine… but it doesn’t feel fine, does it?
The cost of living keeps rising. The divide keeps widening. The anger keeps building.
Listen, I’ve spent three decades studying financial systems, and I’ve never seen pressure like this. It’s as if the old order of the economy has cracked and something new is forcing its way through.
Most people can’t see it yet. But they sense it. They feel it in their gut.
I’ve pulled on that thread for the past year, and what I’ve uncovered is bigger than anything I’ve ever reported. And it’s happening much faster than anyone imagines.
I explain everything in my new documentary.
➡ Watch it here before it’s too late for you.
Good investing,
Porter Stansberry
3 Stocks You'll Wish You Bought Before 2026
Authored by Chris Markoch. Published: 12/3/2025.
Key Takeaways
- These three up-and-coming stocks have delivered triple-digit gains in 2025 and continue to show strong momentum.
- Key catalysts—including clinical milestones, revenue acceleration, and consumer demand—suggest more upside ahead.
- Analysts stay optimistic, with price targets suggesting possible double- or triple-digit gains from current levels.
Many investors have profited from the artificial intelligence (AI) trade in 2025. But there have been several up-and-coming stocks in other sectors that have posted impressive gains this year.
The three stocks in this article remain small by market-cap standards; the largest is just over $4 billion. However, each has made strong moves and reinforced the idea that time in the market often beats trying to time the market.
Punch these codes into your ordinary brokerage account (Ad)
If your retirement strategy involves "picking the right stocks," you're one crash away from disaster…
A hedge fund legend who made $95 million in profits during a crash has a different way.
He's using 18-digit codes to "skim" the market without buying stocks.
And his followers have seen an 84%-win rate.
Of course, if investors could see the future with absolute clarity, investing would be easy. The future is rarely clear, and a bullish outcome is not guaranteed. Still, the charts speak for themselves: investors who bought these names and had the patience to hold through rough stretches are reaping the benefits today. And the rally may not be finished.
Biotech Breakthrough: A Small Cap With a Big 2026 FDA Catalyst
Celcuity Inc. (NASDAQ: CELC) is a clinical-stage biotechnology company that recently reported positive data for its first-in-class PI3K/mTOR inhibitor targeting HR+/HER2- metastatic breast cancer. The company's pivotal Phase 3 VIKTORIA trial is underway, and some expect the company could receive U.S. Food & Drug Administration (FDA) approval in 2026.
Investors have been front-running those results, pushing CELC stock up more than 660%, with nearly all of those gains occurring since the end of July. At $99.30 as of this writing, the stock sits within about 3% of its consensus price target. On Dec. 2, Jefferies raised its price target on the shares to $134 from $108.
The primary risk is the funding required for commercialization. In its most recent earnings report, Celcuity showed a strengthened balance sheet with $455 million in cash, cash equivalents, and short-term investments—up about 72% year-over-year (YOY). Management says that should be sufficient until commercialization begins.
Fintech Disruptor Turning Revenue Growth Into Real Momentum
At a time when traditional banks offer fewer compelling options for many consumers, Dave Inc. (NASDAQ: DAVE) stands out. The Los Angeles-based fintech is best known for its Dave app, which provides affordable, transparent financial tools to users who often live paycheck to paycheck.
The app helps users avoid overdraft fees, budget more effectively, and access short-term cash when needed. The company recently reported a 64% YOY increase in revenue and an adjusted EPS that beat estimates by about 85%.
DAVE stock is up roughly 120% in 2025, and analysts see more upside. As of this writing the shares trade near $208.24, while the consensus price target is $304.25—implying more than 46% upside.
Some investors may balk at a forward price-to-earnings (P/E) ratio near 119x. But analysts are forecasting earnings growth of over 117% in the next 12 months, and that pace of growth can justify a higher multiple if realized.
Resale Retail Winner Riding a Massive Consumer Shift
Consumer staples broadly have had a tough year, but ThredUp Inc. (NASDAQ: TDUP) has been a notable exception. TDUP stock is up more than 430% in 2025, even after a pullback of about 29% in the three months ending Dec. 1.
ThredUp operates an online consignment marketplace, a model that aligns with stretched consumer budgets. The thrift and resale market was a $49 billion industry in 2024 and is projected to expand to $74 billion by 2029.
TDUP is the smallest company on this list, and short interest remains elevated at over 17%, which indicates active trading. That said, the company's Q3 report showed strong YOY revenue growth, a record in new-buyer acquisition, and a 37% YOY increase in orders.
This could be a shorter-term momentum trade for some investors, but the demographic ThredUp serves—younger shoppers who are feeling budgetary pressure—suggests durable demand. Analysts' consensus price target sits at $12.50, about 68% above the closing price on Dec. 1.
This message is a sponsored email from Porter & Company, a third-party advertiser of DividendStocks.com and MarketBeat.
If you need assistance with your subscription, don't hesitate to email MarketBeat's South Dakota based support team at contact@marketbeat.com.
If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.
© 2006-2025 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, S.D. 57103-7078. USA..